Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients.
Orlando
G
G
Fasolo
M M
MM
Schiavini
M
M
Signori
R
R
Cargnel
A
A
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002294:Carcinoma, Squamous Cell / Q000150:complications* / Q000821:virology; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications* / Q000821:virology; D012367:RNA, Viral / Q000097:blood; D002578:Uterine Cervical Dysplasia / Q000150:complications / Q000821:virology; D019562:Viral Load
D019380:Anti-HIV Agents; D012367:RNA, Viral